Benefits of a form of food preservative in treating facial pai
Phase 2
- Conditions
- Health Condition 1: G500- Trigeminal neuralgiaHealth Condition 2: G500- Trigeminal neuralgiaHealth Condition 3: G500- Trigeminal neuralgia
- Registration Number
- CTRI/2018/07/015021
- Lead Sponsor
- Parkinsons Improvement Programme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The TN cases included will be based according to the international headache classification: paroxymal unilateral pain triggered in the anatomical region of the trigeminal nerve without any sensory ormotor focal symptoms in this region.
Exclusion Criteria
Excluded from the study will be the patients with other neurological diseases, severe psychological diseases, serious chronic diseases, such as ischemic heart disease, pulmonary emphysema, and those with history of severe drug allergy. We also excluded patients treated with orally anaesthetics, allergy to vitamin C.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Reduction in TN Symptoms <br/ ><br>2. Clinicians Experience in Managing TNTimepoint: 30mins, 90mins, 24 hours
- Secondary Outcome Measures
Name Time Method Patient reported outcome measures (PROM)Timepoint: 90 mins, 48 hrs, 1 week, one month, 3 months after post intervention